Results
26,743 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $301K 1,446 sh | Mar 6, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $301K 1,446 sh | Mar 6, 2026 |
| 21 | Hershkowitz StevenEVP & Chief Revenue Officer |  RMNIRimini Street, Inc.Open-market sale | SELL | $6,222 1,708 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 21 | Hershkowitz StevenEVP & Chief Revenue Officer | RMNIRimini Street, Inc. Open-market sale | SELL | $13K 3,485 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 21 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $511K 2,457 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 21 | Ramanan NatarajanChief Technology Officer |  ERIIEnergy Recovery, Inc.Open-market sale | SELL | $2,875 272 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 21 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $713K 3,413 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 20 |  David J. TaylorRSelf |  ETNEaton Corp plcSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  CVXCHEVRON CORPSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  AEPAMERICAN ELECTRIC POWER CO INCSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  IBPInstalled Building Products, Inc.Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | Riley JanelChief Accounting Officer |  NETCloudflare, Inc.Open-market sale · 10b5-1 plan | SELL | $4.43M 23.3K sh | Mar 6, 2026 traded Mar 5, 2026 |
| 20 | David J. TaylorRSelf |  FITBFIFTH THIRD BANCORPSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  RPMRPM INTERNATIONAL INC/DE/Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 |  Byron DonaldsRSelf |  PYPLPayPal Holdings, Inc.Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 10, 2026 |
| 20 | Byron DonaldsRSpouse | PYPLPayPal Holdings, Inc. Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 10, 2026 |
| 20 | David J. TaylorRSelf |  MPCMarathon Petroleum CorpSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  PLDPrologis, Inc.Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 20 | David J. TaylorRSelf |  AMGNAMGEN INCSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 19 | Lee Bryan MChief Financial Officer |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $174K 9,855 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Fitzpatrick JenniferChief Legal Officer |  SIONSionna Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $347K 10.3K sh | Mar 6, 2026 traded Mar 5, 2026 |
| 19 | Kozanian PanosEVP, Product Engineering | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 7,002 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 3,369 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 19 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $87K 4,924 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 19 | Kozanian PanosEVP, Product Engineering | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $69K 3,860 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $61K 300 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $239K 1,142 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $127K 612 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $94K 460 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 18 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $70K 340 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 17 | Espinoza OctavioChief Financial Officer | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $300K 1,457 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 16 | David J. TaylorRSelf |  PHParker-Hannifin CorpSale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 16 | David J. TaylorRSelf | PHParker-Hannifin Corp Sale | SELL | $1,001 – $15K | Mar 6, 2026 traded Feb 26, 2026 |
| 16 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 1,756 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $41K 207 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $20K 100 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Mitchell AndreaDirector |  DAVEDave Inc./DEOpen-market sale · 10b5-1 plan | SELL | $389K 1,848 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $866K 4,029 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Mar 6, 2026 traded Mar 4, 2026 |
| 15 | Mitchell AndreaDirector | DAVEDave Inc./DE Open-market sale · 10b5-1 plan | SELL | $411K 1,883 sh | Mar 6, 2026 traded Mar 5, 2026 |
| 15 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $19K 93 sh | Mar 6, 2026 traded Mar 4, 2026 |